Treatment of persistent congenital chylothoraxwith intrapleural injection of sapylin in infants | Hua | Pakistan Journal of Medical Sciences Old Website
 

Treatment of persistent congenital chylothoraxwith intrapleural injection of sapylin in infants

Qing-Wang Hua, Zhi-Yong Lin, Xing-Ti Hu, Qi-Feng Zhao

Abstract


Test the therapeutic efficacy of Sapylin in resolving persistent Congenital Chylothorax (CC) in four infants who failed to respond to conservative medical therapy including Erythromycin and/or Octreotide management. All cases were cured and have no adverse reactions during follow-up. The result shows Sapylin is effective in reducing chylous production.

doi: http://dx.doi.org/10.12669/pjms.325.10142

How to cite this:Hua QW, Lin ZY, Hu XT, Zhao QF. Treatment of persistent congenital chylothorax with intrapleural injection of sapylin in infants. Pak J Med Sci. 2016;32(5):1305-1308.   doi: http://dx.doi.org/10.12669/pjms.325.10142

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


Full Text: PDF

Refbacks

  • There are currently no refbacks.

Comments on this article

View all comments


kalsob-01_1303_01